PNWGS Meet the Professor
Evening Program: 2012 Series
February 9, 2012 (Michel Kahaleh, MD) »
May 31, 2012 (William D. Chey, MD)
September 22, 2012 (State-of-the-Art Endoscopy Course)
October 18, 2012 (Guadalupe Garcia-Tsao, MD)
November 8, 2012 (William J. Sandborn, MD)
Update on EUS: Guided Biliary Drainage
Professor of Clinical Medicine
Chief of Advanced Endoscopy
Weill Cornell Medical College
New York, NY
Michel Kahaleh, MD, AGAF, FACG, FASGE is the Chief of Advanced Endoscopy at Weill Cornell Medical College. Trained in Erasme Hospital,
University of Brussels, he led the Pancreatico-Biliary team of endoscopists at the University of Virginia before joining Weill Cornell
Medical College in July 2011. He is a world renowned endoscopist boarded in both Europe and the United States. He is fluent is French,
Spanish and Arabic.
The adjunct use of both Endoscopic Retrograde Cholangiopancreatography (ERCP) and Endoscopic Ultrasonography (EUS) has permitted him
and his team to successfully treat pancreatic collections and perform newly described procedures that have had a major impact on patient management.
With over 100 publications, Dr. Kahaleh's research has primarily focused on interventional endoscopy. He continually serves as a primary
investigator on many clinical trials; including those that involve the use of new devices to diagnose and treat biliary and pancreatic diseases.
A major focus of his research is on preventing and treating complications of advanced endoscopic procedures. He is actively analyzing the
efficacy of metallic stents in both benign and malignant diseases. Another area of investigation for Dr. Kahaleh is understanding and preventing
biliary and pancreatic cancer. The objective is to develop new diagnostic techniques for reducing the mortality associated with those cancers,
by detecting them earlier and treating them using novel therapies such as laser therapy, photodynamic therapy and radiofrequency ablation.
Read More »
Lecture Topic: TBD
Professor of Medicine,
Director, GI Physiology Labortory
Co-Director, Michigan Bowel Control Program
Division of Gastroenterology
University of Michigan Medical School
Ann Arbor, MI
Dr. Chey received his BA degree from the University of Pennsylvania and medical degree & training in internal medicine
at the Emory University School of Medicine. He went on to complete a fellowship in gastroenterology at the University of
Michigan. Since completing his fellowship, Dr. Chey has remained at the University of Michigan, where he is a Professor of
Medicine, Director of the GI Physiology Laboratory, and Co-Director of the Michigan Bowel Control Program.
Dr. Chey runs a very active clinical research group which has received funding from federal and private sources. His
interests are functional bowel and motility disorders, including irritable bowel syndrome (IBS), constipation, functional
heartburn, non-cardiac chest pain, dysphagia, dyspepsia, and fecal incontinence; as well as H. pylori infection and acid
related disorders, including gastroesophageal reflux disease (GERD) and peptic ulcer disease.
Dr. Chey has authored more than 200 manuscripts, reviews and book chapters. He is Co-editor-in-Chief of the American Journal
of Gastroenterology (2010-2016) and serves on the editorial boards of several other journals. He serves as a member of the Board
of Trustees and Practice Parameters Committee of the American College of Gastroenterology. He is a member of the Board of
Directors of the Rome Foundation and Advisory Board of the IFFGD. He is past Chair of the Clinical Practice Section (2006-2008)
of the AGA. He has participated in and directed numerous national and international continuing medical education programs in
gastroenterology, and has been elected to the roster of "Best Doctors" since 2001 and "America's™ Top Doctors" since 2009.
Dr. Chey was named as one of the "75 Best Gastroenterologists in America" by Becker's ASC in 2010.
Read More »
The 2nd Annual PNWGS State-of-the-Art in Gastrointestinal Endoscopy will be held on September 22 at the
Hyatt at Olive 8
in Downtown Seattle. This course will provide a comprehensive,
state-of-the-art update on all major aspects of gastrointestinal endoscopy. Difficult clinical problems and the role
of new techniques in the diagnosis, management and treatment of a wide variety of gastrointestinal, biliary and
pancreatic disorders will be covered in lectures presented by faculty members who are locally and nationally
recognized experts in the field of endoscopy. There will also be a focus on the latest topics impacting economic,
legal and quality issues in endoscopy, such as health care reform, updates in standards of practice and hot new topics
in medical legal issues.
Lecture Topic: TBD
Professor of Medicine, Digestive Diseases,
Chief, Digestive Diseases, VA-CT Healthcare System;
Director, Clinical and Translational Core, Yale Liver Center
Program Director, VA-CT Hepatitis C Resource Center
Yale University, School of Medicine
New Haven, CT
Dr. Garcia-Tsao is professor of internal medicine at Yale University School of Medicine and staff physician at the Connecticut
Veterans Affairs Healthcare System where she is chief of the Section of Digestive Diseases and program director of the Hepatitis
C Resource Center, one of four such centers nationwide. She is also director of the Clinical Core of the NIH-funded Liver Center at Yale.
Dr. Garcia-Tsao earned her medical degree from the Universidad Nacional Autónoma de México in Mexico City and completed her internal
medicine residency and gastroenterology fellowship at the Instituto Nacional de la Nutrición in Mexico City. She completed training
in hepatology at Yale University and joined its faculty in 1989. She has published more than 100 original articles, chapters and reviews.
Dr. Garcia-Tsao’s research has been mainly in the area of the complications of cirrhosis, specifically varices, variceal hemorrhage,
ascites, spontaneous bacterial peritonitis and hepatorenal syndrome. She was part of the research team that established the threshold
portal pressure level for the development of varices, that performed the only placebo-controlled study of propranolol in the prevention
of first variceal hemorrhage and that performed a study defining the cutoff ascites polymorphonuclear cell count in the diagnosis of SBP.
Her research has also defined the clinical characteristics and outcome of liver vascular malformations in hereditary hemorrhagic telangiectasia.
She has served as a member of the NIDDK-C Study Section of NIH and served as associate editor of the Journal of Hepatology. She has
been a member of various international consensus conference teams that have established current standards in the treatment of portal
hypertension and its complications. She was a part of the team that prepared the recent AASLD/ACG guidelines for the management of
varices and variceal hemorrhage. Dr. Garcia-Tsao has participated in many AASLD activities and committees. She has served as secretary,
chaired the education oversight committee and the membership committee and served as co-organizer of a research workshop and a
single topic conference.
Read More »
November 8, 2012
Lecture Topic: TBD
Professor of Medicine and Chief,
Division of Gastroenterology
University of California, San Diego
School of Medicine
San Diego, CA
Dr. William Sandborn is Professor of Medicine and Chief of the Division of Gastroenterology at the University of California,
San Diego, School of Medicine. He directs a large clinical research unit devoted to the conduct of clinical trials in
inflammatory bowel disease, where he supervises a multi-investigator team of physicians, research fellows, nurses, and study
coordinators. With his physician collaborators, he evaluates and develops new diagnostic modalities and medical therapies for
inflammatory bowel disease. He is internationally recognized for his contributions in the fields of biotechnology therapy,
clinical pharmacology, conduct of clinical trials, diagnostic and treatment of pouchitis, epidemiology and natural history,
and endoscopic and radiographic imaging techniques.
Dr. Sandborn completed medical school and an internal medicine residency at Loma Linda University in Loma Linda California.
He completed a gastroenterology fellowship at the Mayo Clinic in Rochester Minnesota in 1993. Prior to his position at UCSD,
he was professor of medicine and the Dorothy A. Adair professor of gastrointestinal research at Mayo Clinic College of Medicine.
Dr. Sandborn has published more than 359 articles including articles in the
New England Journal of Medicine, the
Lancet,
JAMA, the
Annals of Internal Medicine, and
Gastroenterology. His research interests are clinical trials
and clinical pharmacology related to inflammatory bowel disease.
Read More »